CzMA JEP Home page CZECH MEDICAL ASSOCIATION J. Ev. PURKYNĚ
Journals - Article
CzMA JEP Home page News About Assocation Publishing Division Medical Journals Searching Supplements Catalogue
 
  Česky / Czech version Čes.-slov. Patol., 39, 2003, No. 3, p. 138 - 142
 
2p13-16 Amplification in Extranodal Diffuse Large B-cell Lymphoma with Rapid Lethal Course Resistent to Chemotherapy: a Case Report 
Hušek K.1, Peťovská P.2, Procházková D.3 

1I. patologickoanatomický ústav MU, FN u sv. Anny, Brno 2Oddělení lékařské genetiky MU, FN u sv. Anny, Brno 3I. dětská interní klinika, FN Brno, pracoviště Dětská nemocnice, Brno
 


Summary:

       Comparative genomic hybridisation (CGH) allows to detect genetic abnormalities associated with poor prognosis in subset of patients with diffuse large B-cell lymphoma (DLBCL). Amplification of 2p13-16 represents an adverse genetic sign especially in extranodal DLBCL. In the present case, 2p13-16 amplification was revealed by CGH in extranodal DLBCL. It was localized in the mesentery and remained resistant to the chemotherapy (CHOP). A patient, 72-year-old female, died 10 weeks after the diagnosis had been made. Rapid lethal course of the disease confirms poor outlook for patients with 2p13-16 and supports a role of CGH as a sensitive method in prognosis for patients with DLBCL.

        Key words: comparative genomic hybridization – 2p13-16 amplification – diffuse large B-cell lymphoma
       

Order this issue

  BACK TO CONTENTS  
 
 
| HOME PAGE | CODE PAGE | CZECH VERSION |
©  1998 - 2008 CZECH MEDICAL ASSOCIATION J. E. PURKYNĚ
Created by: NT Servis, s.r.o., hosted by P.E.S. consulting, s.r.o.
WEBMASTER